Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Santiago Pérez-Lloret
Based on 46 articles published since 2008
||||
Expertise Level
The expertise of Santiago Pérez-Lloret ranks in the
  • Top 0.086%
  • ... of 66,284 published authors worldwide on Parkinson Disease
  • ... from 2008 through 2018
  • ... based on contributions to 46 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Perez Lloret, S   ·   Perez-Lloret, Santiago   ·   Perez-Lloret, S   ·   Perez Lloret, Santiago   ·   Pérez Lloret, S   ·   Pérez-Lloret, Santiago
Work Locations
Details
Most likely:    Universite de Toulouse      
2017
  • INSERM, Services de Pharmacologie Clinique et Neurosciences, Centre d'Investigation Clinique CIC 1436, NS-Park/FCRIN Network, NeuroToul COEN Center, Université de Toulouse UPS, CHU de Toulouse, Toulouse, France. · Institute of Cardiology Research, University of Buenos Aires, National Research Council (CONICET-ININCA), Buenos Aires, Argentina. · LN Pharma, Toulouse. · Département d'Information Médicale, Unité de Recherche Clinique et Epidémiologie, Hôpital la Colombière, Montpellier. · Department of Neurology, INSERM, NS-Park/FCRIN Network, Université de Nantes, CHU de Nantes, Nantes. · Department of Neurology, INSERM, NS-Park/FCRIN Network, Université de Lille, CHU de Lille, U 837 Eq6, Lille. · CNRS, CHU de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Service de Neurologie, NS-Park/FCRIN Network, Université de Bordeaux, Bordeaux, France. · Pubmed 28940893
2015
  • Department of Clinical Pharmacology, Paul Sabatier University and Toulouse University Hospital, Toulouse, France; INSERM UMR825 Neuroimaging and Neurologic Diseases, Toulouse, France; Sleep and Epilepsy Center, Neurocenter of Southern Switzerland, Civic Hospital (EOC) of Lugano, Switzerland. Electronic address: · Department of Clinical Pharmacology, Paul Sabatier University and Toulouse University Hospital, Toulouse, France; LN-Pharma, Toulouse, France. · Department of Clinical Pharmacology, Paul Sabatier University and Toulouse University Hospital, Toulouse, France. · Sleep Medicine and Epilepsy Unit, IRCCS "C. Mondino National Institute of Neurology" Foundation, Pavia, Italy. · Pôle Neurosciences, Centre Hospitalier Universitaire de Nantes, Centre d'Investigation Clinique CIC 04, Nantes, France. · Service de Neurologie, Groupe Hospitalier Sud, Hôpital Haut-Lévèque, Centre Hospitalier Universitaire de Bordeaux, France. · Service de Neurologie et pathologie du mouvement, Pôle de Neurologie, Centre Hospitalier Universitaire de Lille, France. · Department of Clinical Pharmacology, Paul Sabatier University and Toulouse University Hospital, Toulouse, France; INSERM UMR825 Neuroimaging and Neurologic Diseases, Toulouse, France; Centre d'Investigation Clinique CIC 9302, Toulouse University Hospital, Toulouse, France. · Pubmed 26411501
  • Department of Clinical Pharmacology and Neurosciences, University of Toulouse 3, 37 Allées Jules Guesde, 31000, Toulouse, France. · INSERM CIC1436 and UMR825, Toulouse, France. · NS-Park Network, INSERM, Toulouse, France. · Department of Clinical Pharmacology and Neurosciences, University of Toulouse 3, 37 Allées Jules Guesde, 31000, Toulouse, France. · Laboratory of Epidemiology and Experimental Pharmacology, Institute for Biomedical Research (BIOMED-CONICET), Faculty of Medical Sciences, Pontifical Catholic University of Argentina (UCA), Buenos Aires, Argentina. · NS-Park Network, INSERM, Toulouse, France. · Department of Neurology, Hôpital Laënnec, CHU Nantes, Nantes, France. · Department of Neurology, CHU Lille, Lille, France. · Department of Neurology, Hôpital Laënnec, CHU Nantes, Nantes, France. · NS-Park Network, INSERM, Toulouse, France. · Department of Neurology, CHU Lille, Lille, France. · INSERM U 837 Eq6, Lille, France. · Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, Bordeaux, France. · Institut des Maladies Neurodégénératives, UMR 5293, CNRS, Bordeaux, France. · Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · NS-Park Network, INSERM, Toulouse, France. · Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, Bordeaux, France. · Institut des Maladies Neurodégénératives, UMR 5293, CNRS, Bordeaux, France. · Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · NS-Park Network, INSERM, Toulouse, France. · LN Pharma, Toulouse, France. · Pubmed 25845678
2014
  • Hospital and University Paul Sabatier of Toulouse, France and INSERM CIC9023 and UMR 825, Department of Clinical Pharmacology and Neurosciences , Toulouse , France. · Pubmed 24547918
  • Department of Clinical Pharmacology, Faculty of Medicine, University Hospital, University of Toulouse, Toulouse, France2Department of Neurosciences, University Hospital, University of Toulouse, Toulouse, France3Clinical Investigation Center 1436, Universi. · LN Pharma, Toulouse, France. · Department of Neurology, Hôpital Laënnec, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France6NS-Park Network, INSERM, Toulouse, France. · Department of Neurology, CHU Lille, Lille, France. · NS-Park Network, INSERM, Toulouse, France7Department of Neurology, CHU Lille, Lille, France8INSERM U 837 Eq6, Lille, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, Bordeaux, France10Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France11Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · Neurology Department, Kantonsspital Münsterlingen, Münsterlingen, Switzerland. · NS-Park Network, INSERM, Toulouse, France9Institut des Maladies Neurodégénératives, Université de Bordeaux, Bordeaux, France10Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France11Service de Neurologie. · Pubmed 24839938
2013
  • Department of Clinical Pharmacology, Toulouse University Hospital & Clinical Pharmacology & Epidemiology Laboratory, Buenos Aires Catholic University, Buenos Aires, Argentina. · Pubmed 23398475
  • University of Toulouse III, University Hospital, Department of Clinical Pharmacology and Neuroscience, Toulouse, France. · Pubmed 23373820
  • Departments of Clinical Pharmacology and Neurosciences, University Hospital, University of Toulouse, Toulouse, France. · Pubmed 22320451
2012
  • University Hospital and University Paul Sabatier Toulouse 3, Departments of Clinical Pharmacology and Neurosciences, France. · Pubmed 22530847
  • Laboratoire de Pharmacologie Médicale et Clinique, INSERM U 1027 Equipe de PharmacoEpidémiologie, l'Université de Toulouse, Toulouse, France. · Pubmed 22336566
  • Laboratoire de Pharmacologie Médicale et Clinique, INSERM U 1027 Equipe de PharmacoEpidémiologie, Faculté de Médecine, Université de Toulouse, Toulouse, France. · Pubmed 22205275
  • Department of Clinical Pharmacology, University Hospital and University of Toulouse, Toulouse, France. · Pubmed 21453441
2011
  • Departments of Clinical Pharmacology and Neurosciences, University Hospital and University of Toulouse, France and INSERM CIC-9023 and UMR-825, Toulouse, France; Department of Clinical Pharmacology, Faculty of Medicine, 37 Allées Jules Guesde, 31000, Toulouse, France. · Pubmed 21721909
2010
  • Department of Clinical Pharmacology and Neurosciences, Hospital and University of Toulouse and INSERM CIC9023 and UMR 825, Toulouse, France. · Pubmed 20932066
  • Department of Clinical Pharmacology, University of Toulouse, Faculty of Medicine, 37 Allées Jules Guesde, 31000 Toulouse, France. · Pubmed 20670197
2014
  • Departments of Clinical Pharmacology and Neurosciences, Faculty of Medicine, University Hospital and University of Toulouse 3, 37 Allées Jules Guesde, 31000, Toulouse, France, · Pubmed 24683045
2012
  • Department of Clinical Pharmacology, Hospital and University Paul Sabatier of Toulouse, France. · Pubmed 21585523
Probable:    Universidad de Buenos Aires      
2017
  • a Institute of Cardiology Research , University of Buenos Aires, National Research Council (ININCA-UBA-CONICET) , Buenos Aires , Argentina. · b Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud , Universidad Autónoma de Chile , Santiago de Chile , Chile. · Pubmed 28836869
  • INSERM, Services de Pharmacologie Clinique et Neurosciences, Centre d'Investigation Clinique CIC 1436, NS-Park/FCRIN Network, NeuroToul COEN Center, Université de Toulouse UPS, CHU de Toulouse, Toulouse, France. · Institute of Cardiology Research, University of Buenos Aires, National Research Council (CONICET-ININCA), Buenos Aires, Argentina. · LN Pharma, Toulouse. · Département d'Information Médicale, Unité de Recherche Clinique et Epidémiologie, Hôpital la Colombière, Montpellier. · Department of Neurology, INSERM, NS-Park/FCRIN Network, Université de Nantes, CHU de Nantes, Nantes. · Department of Neurology, INSERM, NS-Park/FCRIN Network, Université de Lille, CHU de Lille, U 837 Eq6, Lille. · CNRS, CHU de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Service de Neurologie, NS-Park/FCRIN Network, Université de Bordeaux, Bordeaux, France. · Pubmed 28940893
2016
  • a Institute of Cardiology Research, National Scientific and Research Council (ININCA-CONICET), Faculty of Medicine , University of Buenos Aires , Buenos Aires , Argentina. · Pubmed 26757448
  • a Institute of Cardiology Research , University of Buenos Aires, National Research Council (CONICET-ININCA) , Buenos Aires , Argentina. · b Parkinson's Disease and Movement Disorders Clinic, Neurology Department , CEMIC University Hospital , Buenos Aires , Argentina. · c Laboratory of Molecular Neurobiology , Institute for Biomedical Research, UCA-CONICET, Faculty of Medical Sciences , Buenos Aires , Argentina. · Pubmed 27785919
  • Institute of Cardiology Research, University of Buenos Aires, National Research Council (CONICET-ININCA), Buenos Aires, Argentina. · Department of Clinical Pharmacology and Neurosciences and NeuroToul Center of Excellence in Neurodegeneration (COEN), University Hospital and University of Toulouse III, Toulouse, France. · INSERM CIC1436 and UMR1214, Toulouse, France. · NS-Park/FCRIN Network, INSERM, Toulouse, France. · Pubmed 27344665
  • a Institute of Cardiologic Research, National Scientific and Research Council (ININCA-CONICET), Faculty of Medicine , University of Buenos Aires , Buenos Aires , Argentina. · b Department of Clinical Pharmacology and Neurosciences , NeuroToul Excellence Center for Neurodegenerative Disorders, University Hospital and University of Toulouse 3 , Toulouse , France. · c INSERM CIC1436 and UMR825 , Toulouse , France. · d NS-Park Network, INSERM , Toulouse , France. · Pubmed 26849427
  • McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada. · Fulbright Canada Student, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America. · Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America. · Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America. · Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America. · Cerner Corporation, Kansas City, Missouri, United States of America. · C. T. Lamont Primary Health Care Research Centre, Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada. · Bruyère Research Institute, Ottawa, Ontario, Canada. · School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Ontario, Canada. · Cardiology Research Institute, University of Buenos Aires, National Research Council (ININCA-UBA-CONICET), Buenos Aires, Argentina. · Risk Sciences International, Ottawa, Ontario, Canada. · Pubmed 26939130
Probable:    Miscellaneous institutions in Buenos Aires      
2016
  • Pain Center, Department of Neurology, University of São Paulo, São Paulo, Brazil. · Pain Center, Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil. · Movement Disorders Group, Department of Neurology, University of São Paulo, São Paulo, Brazil. · Transcranial Magnetic Stimulation Laboratory, Psychiatry Institute, University of São Paulo, São Paulo, Brazil. · Neurosurgery Division, Department of Neurology, University of São Paulo, São Paulo, Brazil. · Laboratory of Clinical Pharmacology and Epidemiology, Catholic University, Buenos Aires, Argentina. · Pubmed 26147660
2015
  • Department of Clinical Pharmacology and Neurosciences, University Hospital and University of Toulouse 3, France. · INSERM CIC1436 and UMR825, Toulouse, France. · Laboratory of Epidemiology and Experimental Pharmacology, Institute for Biomedical Research (BIOMED), School of Medical Sciences, Pontifical Catholic University of Argentina (UCA). · National Scientific and Technological Research Council (CONICET), Buenos Aires, Argentina. · Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. · Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Portugal. · Pubmed 26293004
  • Movement Disorders Section, Neuroscience Department, Raul Carrea Institute for Neurological Research (FLENI), Montañeses, Argentina. · Laboratory of Epidemiology and Experimental Pharmacology, Institute for Biomedical Research (BIOMED), School of Medical Sciences, Pontifical Catholic University of Argentina (UCA), Buenos Aires, Argentina. · Argentine National Scientific and Technological Research Council (CONICET), Buenos Aires, Argentina. · Cognitive Neurology and Psychiatry Department, Raul Carrea Institute for Neurological Research (FLENI), Montañeses, Argentina. · Pubmed 26096632
  • Department of Clinical Pharmacology and Neurosciences, University of Toulouse 3, 37 Allées Jules Guesde, 31000, Toulouse, France. · INSERM CIC1436 and UMR825, Toulouse, France. · NS-Park Network, INSERM, Toulouse, France. · Department of Clinical Pharmacology and Neurosciences, University of Toulouse 3, 37 Allées Jules Guesde, 31000, Toulouse, France. · Laboratory of Epidemiology and Experimental Pharmacology, Institute for Biomedical Research (BIOMED-CONICET), Faculty of Medical Sciences, Pontifical Catholic University of Argentina (UCA), Buenos Aires, Argentina. · NS-Park Network, INSERM, Toulouse, France. · Department of Neurology, Hôpital Laënnec, CHU Nantes, Nantes, France. · Department of Neurology, CHU Lille, Lille, France. · Department of Neurology, Hôpital Laënnec, CHU Nantes, Nantes, France. · NS-Park Network, INSERM, Toulouse, France. · Department of Neurology, CHU Lille, Lille, France. · INSERM U 837 Eq6, Lille, France. · Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, Bordeaux, France. · Institut des Maladies Neurodégénératives, UMR 5293, CNRS, Bordeaux, France. · Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · NS-Park Network, INSERM, Toulouse, France. · Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, Bordeaux, France. · Institut des Maladies Neurodégénératives, UMR 5293, CNRS, Bordeaux, France. · Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · NS-Park Network, INSERM, Toulouse, France. · LN Pharma, Toulouse, France. · Pubmed 25845678
2010
  • Movement Disorders Section, Raul Carrea Institute for Neurological Research, FLENI Buenos Aires, Argentina. · Pubmed 20199206
  • Movement Disorders Section, Raul Carrea Institute for Neurological Research, FLENI, Buenos Aires, Argentina. · Pubmed 20128666
2009
  • Movement Disorders Section, Raul Carrea Institute for Neurological Research, FLENI, Montañeses 2325 C1428AQK, Cdad Aut Buenos Aires, Argentina. · Pubmed 19404716
2008
  • Movement Disorders Section, Raul Carrea Institute for Neurological Research, FLENI, Montañeses 2325, C1428AQK Cdad. Aut. Buenos Aires, Argentina. · Pubmed 18329317
2015
  • Raul Carrea Institute for Neurological Research (FLENI), Neuroscience Department, Movement Disorders Section , Buenos Aires , Argentina. · Pubmed 25539892
2014
  • Raul Carrea Institute for Neurological Research, Movement Disorders Section , Montañeses 2325 (1425), Buenos Aires , Argentina +54 11 57773200 · +54 11 57773200 · · Pubmed 24673462
2012
  • Movement Disorders Section, Neuroscience Department, Institute for Neurological Research Raul Carrea, FLENI, Montañeses 232, 1428 Buenos Aires, Buenos Aires, Argentina. · Pubmed 22227345
2010
  • Movement Disorders Section, Raul Carrea Institute for Neurological Research, FLENI, Buenos Aires, Argentina. · Pubmed 19780806
2009
  • Movement Disorders Section, Raúl Carrea Institute for Neurological Research (FLENI), Buenos Aires, Argentina. · Pubmed 19916854
  • Movement Disorders Section, Neuroscience Department and Cognitive Department, Institute for Neurological Research Raul Carrea FLENI, Buenos Aires, Argentina. · Pubmed 19049504
2008
  • Neuroscience Department, Raul Carrea Institute for Neurological Research, Montañeses 2325, Buenos Aires, Argentina. · Pubmed 18568731
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 46 total) written by Santiago Pérez-Lloret about Parkinson Disease:

  • Renin-angiotensin system as a potential target for new therapeutic approaches in Parkinson's disease. 2017
  • L-DOPA-induced dyskinesias, motor fluctuations and health-related quality of life: the COPARK survey. 2017
  • Investigational drugs for autonomic dysfunction in Parkinson's disease. 2016
  • Pharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration. 2016
  • Piribedil for the Treatment of Motor and Non-motor Symptoms of Parkinson Disease. 2016
  • The safety and efficacy of safinamide mesylate for the treatment of Parkinson's disease. 2016
  • Sensory abnormalities and pain in Parkinson disease and its modulation by treatment of motor symptoms. 2016
  • Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease. 2016
  • Comparison of Olfactory Identification Patterns among Parkinson's Disease Patients from Different Countries. 2016
  • New treatments for levodopa-induced motor complications. 2015
Show List of Full Article Records
Google Searches

Learn more about Santiago Pérez-Lloret using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Universite de Toulouse
Universidad de Buenos Aires
Miscellaneous institutions in Buenos Aires
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Universite de Toulouse
2017
  • INSERM, Services de Pharmacologie Clinique et Neurosciences, Centre d'Investigation Clinique CIC 1436, NS-Park/FCRIN Network, NeuroToul COEN Center, Université de Toulouse UPS, CHU de Toulouse, Toulouse, France. · Institute of Cardiology Research, University of Buenos Aires, National Research Council (CONICET-ININCA), Buenos Aires, Argentina. · LN Pharma, Toulouse. · Département d'Information Médicale, Unité de Recherche Clinique et Epidémiologie, Hôpital la Colombière, Montpellier. · Department of Neurology, INSERM, NS-Park/FCRIN Network, Université de Nantes, CHU de Nantes, Nantes. · Department of Neurology, INSERM, NS-Park/FCRIN Network, Université de Lille, CHU de Lille, U 837 Eq6, Lille. · CNRS, CHU de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Service de Neurologie, NS-Park/FCRIN Network, Université de Bordeaux, Bordeaux, France. · Pubmed 28940893
2015
  • Department of Clinical Pharmacology, Paul Sabatier University and Toulouse University Hospital, Toulouse, France; INSERM UMR825 Neuroimaging and Neurologic Diseases, Toulouse, France; Sleep and Epilepsy Center, Neurocenter of Southern Switzerland, Civic Hospital (EOC) of Lugano, Switzerland. Electronic address: · Department of Clinical Pharmacology, Paul Sabatier University and Toulouse University Hospital, Toulouse, France; LN-Pharma, Toulouse, France. · Department of Clinical Pharmacology, Paul Sabatier University and Toulouse University Hospital, Toulouse, France. · Sleep Medicine and Epilepsy Unit, IRCCS "C. Mondino National Institute of Neurology" Foundation, Pavia, Italy. · Pôle Neurosciences, Centre Hospitalier Universitaire de Nantes, Centre d'Investigation Clinique CIC 04, Nantes, France. · Service de Neurologie, Groupe Hospitalier Sud, Hôpital Haut-Lévèque, Centre Hospitalier Universitaire de Bordeaux, France. · Service de Neurologie et pathologie du mouvement, Pôle de Neurologie, Centre Hospitalier Universitaire de Lille, France. · Department of Clinical Pharmacology, Paul Sabatier University and Toulouse University Hospital, Toulouse, France; INSERM UMR825 Neuroimaging and Neurologic Diseases, Toulouse, France; Centre d'Investigation Clinique CIC 9302, Toulouse University Hospital, Toulouse, France. · Pubmed 26411501
  • Department of Clinical Pharmacology and Neurosciences, University of Toulouse 3, 37 Allées Jules Guesde, 31000, Toulouse, France. · INSERM CIC1436 and UMR825, Toulouse, France. · NS-Park Network, INSERM, Toulouse, France. · Department of Clinical Pharmacology and Neurosciences, University of Toulouse 3, 37 Allées Jules Guesde, 31000, Toulouse, France. · Laboratory of Epidemiology and Experimental Pharmacology, Institute for Biomedical Research (BIOMED-CONICET), Faculty of Medical Sciences, Pontifical Catholic University of Argentina (UCA), Buenos Aires, Argentina. · NS-Park Network, INSERM, Toulouse, France. · Department of Neurology, Hôpital Laënnec, CHU Nantes, Nantes, France. · Department of Neurology, CHU Lille, Lille, France. · Department of Neurology, Hôpital Laënnec, CHU Nantes, Nantes, France. · NS-Park Network, INSERM, Toulouse, France. · Department of Neurology, CHU Lille, Lille, France. · INSERM U 837 Eq6, Lille, France. · Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, Bordeaux, France. · Institut des Maladies Neurodégénératives, UMR 5293, CNRS, Bordeaux, France. · Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · NS-Park Network, INSERM, Toulouse, France. · Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, Bordeaux, France. · Institut des Maladies Neurodégénératives, UMR 5293, CNRS, Bordeaux, France. · Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · NS-Park Network, INSERM, Toulouse, France. · LN Pharma, Toulouse, France. · Pubmed 25845678
2014
  • Hospital and University Paul Sabatier of Toulouse, France and INSERM CIC9023 and UMR 825, Department of Clinical Pharmacology and Neurosciences , Toulouse , France. · Pubmed 24547918
  • Department of Clinical Pharmacology, Faculty of Medicine, University Hospital, University of Toulouse, Toulouse, France2Department of Neurosciences, University Hospital, University of Toulouse, Toulouse, France3Clinical Investigation Center 1436, Universi. · LN Pharma, Toulouse, France. · Department of Neurology, Hôpital Laënnec, Centre Hospitalier Universitaire (CHU) Nantes, Nantes, France6NS-Park Network, INSERM, Toulouse, France. · Department of Neurology, CHU Lille, Lille, France. · NS-Park Network, INSERM, Toulouse, France7Department of Neurology, CHU Lille, Lille, France8INSERM U 837 Eq6, Lille, France. · Institut des Maladies Neurodégénératives, Université de Bordeaux, Bordeaux, France10Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France11Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · Neurology Department, Kantonsspital Münsterlingen, Münsterlingen, Switzerland. · NS-Park Network, INSERM, Toulouse, France9Institut des Maladies Neurodégénératives, Université de Bordeaux, Bordeaux, France10Centre National de la Recherche Scientifique, Institut des Maladies Neurodégénératives, Bordeaux, France11Service de Neurologie. · Pubmed 24839938
2013
  • Department of Clinical Pharmacology, Toulouse University Hospital & Clinical Pharmacology & Epidemiology Laboratory, Buenos Aires Catholic University, Buenos Aires, Argentina. · Pubmed 23398475
  • University of Toulouse III, University Hospital, Department of Clinical Pharmacology and Neuroscience, Toulouse, France. · Pubmed 23373820
  • Departments of Clinical Pharmacology and Neurosciences, University Hospital, University of Toulouse, Toulouse, France. · Pubmed 22320451
2012
  • University Hospital and University Paul Sabatier Toulouse 3, Departments of Clinical Pharmacology and Neurosciences, France. · Pubmed 22530847
  • Laboratoire de Pharmacologie Médicale et Clinique, INSERM U 1027 Equipe de PharmacoEpidémiologie, l'Université de Toulouse, Toulouse, France. · Pubmed 22336566
  • Laboratoire de Pharmacologie Médicale et Clinique, INSERM U 1027 Equipe de PharmacoEpidémiologie, Faculté de Médecine, Université de Toulouse, Toulouse, France. · Pubmed 22205275
  • Department of Clinical Pharmacology, University Hospital and University of Toulouse, Toulouse, France. · Pubmed 21453441
2011
  • Departments of Clinical Pharmacology and Neurosciences, University Hospital and University of Toulouse, France and INSERM CIC-9023 and UMR-825, Toulouse, France; Department of Clinical Pharmacology, Faculty of Medicine, 37 Allées Jules Guesde, 31000, Toulouse, France. · Pubmed 21721909
2010
  • Department of Clinical Pharmacology and Neurosciences, Hospital and University of Toulouse and INSERM CIC9023 and UMR 825, Toulouse, France. · Pubmed 20932066
  • Department of Clinical Pharmacology, University of Toulouse, Faculty of Medicine, 37 Allées Jules Guesde, 31000 Toulouse, France. · Pubmed 20670197
2014
  • Departments of Clinical Pharmacology and Neurosciences, Faculty of Medicine, University Hospital and University of Toulouse 3, 37 Allées Jules Guesde, 31000, Toulouse, France, · Pubmed 24683045
2012
  • Department of Clinical Pharmacology, Hospital and University Paul Sabatier of Toulouse, France. · Pubmed 21585523
Universidad de Buenos Aires
2017
  • a Institute of Cardiology Research , University of Buenos Aires, National Research Council (ININCA-UBA-CONICET) , Buenos Aires , Argentina. · b Instituto de Ciencias Biomédicas, Facultad de Ciencias de la Salud , Universidad Autónoma de Chile , Santiago de Chile , Chile. · Pubmed 28836869
  • INSERM, Services de Pharmacologie Clinique et Neurosciences, Centre d'Investigation Clinique CIC 1436, NS-Park/FCRIN Network, NeuroToul COEN Center, Université de Toulouse UPS, CHU de Toulouse, Toulouse, France. · Institute of Cardiology Research, University of Buenos Aires, National Research Council (CONICET-ININCA), Buenos Aires, Argentina. · LN Pharma, Toulouse. · Département d'Information Médicale, Unité de Recherche Clinique et Epidémiologie, Hôpital la Colombière, Montpellier. · Department of Neurology, INSERM, NS-Park/FCRIN Network, Université de Nantes, CHU de Nantes, Nantes. · Department of Neurology, INSERM, NS-Park/FCRIN Network, Université de Lille, CHU de Lille, U 837 Eq6, Lille. · CNRS, CHU de Bordeaux, Institut des Maladies Neurodégénératives, UMR 5293, Service de Neurologie, NS-Park/FCRIN Network, Université de Bordeaux, Bordeaux, France. · Pubmed 28940893
2016
  • a Institute of Cardiology Research, National Scientific and Research Council (ININCA-CONICET), Faculty of Medicine , University of Buenos Aires , Buenos Aires , Argentina. · Pubmed 26757448
  • a Institute of Cardiology Research , University of Buenos Aires, National Research Council (CONICET-ININCA) , Buenos Aires , Argentina. · b Parkinson's Disease and Movement Disorders Clinic, Neurology Department , CEMIC University Hospital , Buenos Aires , Argentina. · c Laboratory of Molecular Neurobiology , Institute for Biomedical Research, UCA-CONICET, Faculty of Medical Sciences , Buenos Aires , Argentina. · Pubmed 27785919
  • Institute of Cardiology Research, University of Buenos Aires, National Research Council (CONICET-ININCA), Buenos Aires, Argentina. · Department of Clinical Pharmacology and Neurosciences and NeuroToul Center of Excellence in Neurodegeneration (COEN), University Hospital and University of Toulouse III, Toulouse, France. · INSERM CIC1436 and UMR1214, Toulouse, France. · NS-Park/FCRIN Network, INSERM, Toulouse, France. · Pubmed 27344665
  • a Institute of Cardiologic Research, National Scientific and Research Council (ININCA-CONICET), Faculty of Medicine , University of Buenos Aires , Buenos Aires , Argentina. · b Department of Clinical Pharmacology and Neurosciences , NeuroToul Excellence Center for Neurodegenerative Disorders, University Hospital and University of Toulouse 3 , Toulouse , France. · c INSERM CIC1436 and UMR825 , Toulouse , France. · d NS-Park Network, INSERM , Toulouse , France. · Pubmed 26849427
  • McLaughlin Centre for Population Health Risk Assessment, University of Ottawa, Ottawa, Ontario, Canada. · Fulbright Canada Student, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America. · Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America. · Department of Biostatistics and Epidemiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America. · Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, United States of America. · Cerner Corporation, Kansas City, Missouri, United States of America. · C. T. Lamont Primary Health Care Research Centre, Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada. · Bruyère Research Institute, Ottawa, Ontario, Canada. · School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Ontario, Canada. · Cardiology Research Institute, University of Buenos Aires, National Research Council (ININCA-UBA-CONICET), Buenos Aires, Argentina. · Risk Sciences International, Ottawa, Ontario, Canada. · Pubmed 26939130
Miscellaneous institutions in Buenos Aires
2016
  • Pain Center, Department of Neurology, University of São Paulo, São Paulo, Brazil. · Pain Center, Instituto do Câncer do Estado de São Paulo, São Paulo, Brazil. · Movement Disorders Group, Department of Neurology, University of São Paulo, São Paulo, Brazil. · Transcranial Magnetic Stimulation Laboratory, Psychiatry Institute, University of São Paulo, São Paulo, Brazil. · Neurosurgery Division, Department of Neurology, University of São Paulo, São Paulo, Brazil. · Laboratory of Clinical Pharmacology and Epidemiology, Catholic University, Buenos Aires, Argentina. · Pubmed 26147660
2015
  • Department of Clinical Pharmacology and Neurosciences, University Hospital and University of Toulouse 3, France. · INSERM CIC1436 and UMR825, Toulouse, France. · Laboratory of Epidemiology and Experimental Pharmacology, Institute for Biomedical Research (BIOMED), School of Medical Sciences, Pontifical Catholic University of Argentina (UCA). · National Scientific and Technological Research Council (CONICET), Buenos Aires, Argentina. · Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. · Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Portugal. · Pubmed 26293004
  • Movement Disorders Section, Neuroscience Department, Raul Carrea Institute for Neurological Research (FLENI), Montañeses, Argentina. · Laboratory of Epidemiology and Experimental Pharmacology, Institute for Biomedical Research (BIOMED), School of Medical Sciences, Pontifical Catholic University of Argentina (UCA), Buenos Aires, Argentina. · Argentine National Scientific and Technological Research Council (CONICET), Buenos Aires, Argentina. · Cognitive Neurology and Psychiatry Department, Raul Carrea Institute for Neurological Research (FLENI), Montañeses, Argentina. · Pubmed 26096632
  • Department of Clinical Pharmacology and Neurosciences, University of Toulouse 3, 37 Allées Jules Guesde, 31000, Toulouse, France. · INSERM CIC1436 and UMR825, Toulouse, France. · NS-Park Network, INSERM, Toulouse, France. · Department of Clinical Pharmacology and Neurosciences, University of Toulouse 3, 37 Allées Jules Guesde, 31000, Toulouse, France. · Laboratory of Epidemiology and Experimental Pharmacology, Institute for Biomedical Research (BIOMED-CONICET), Faculty of Medical Sciences, Pontifical Catholic University of Argentina (UCA), Buenos Aires, Argentina. · NS-Park Network, INSERM, Toulouse, France. · Department of Neurology, Hôpital Laënnec, CHU Nantes, Nantes, France. · Department of Neurology, CHU Lille, Lille, France. · Department of Neurology, Hôpital Laënnec, CHU Nantes, Nantes, France. · NS-Park Network, INSERM, Toulouse, France. · Department of Neurology, CHU Lille, Lille, France. · INSERM U 837 Eq6, Lille, France. · Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, Bordeaux, France. · Institut des Maladies Neurodégénératives, UMR 5293, CNRS, Bordeaux, France. · Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · NS-Park Network, INSERM, Toulouse, France. · Institut des Maladies Neurodégénératives, UMR 5293, Université de Bordeaux, Bordeaux, France. · Institut des Maladies Neurodégénératives, UMR 5293, CNRS, Bordeaux, France. · Service de Neurologie, CHU de Bordeaux, Bordeaux, France. · NS-Park Network, INSERM, Toulouse, France. · LN Pharma, Toulouse, France. · Pubmed 25845678
2010
  • Movement Disorders Section, Raul Carrea Institute for Neurological Research, FLENI Buenos Aires, Argentina. · Pubmed 20199206
  • Movement Disorders Section, Raul Carrea Institute for Neurological Research, FLENI, Buenos Aires, Argentina. · Pubmed 20128666
2009
  • Movement Disorders Section, Raul Carrea Institute for Neurological Research, FLENI, Montañeses 2325 C1428AQK, Cdad Aut Buenos Aires, Argentina. · Pubmed 19404716
2008
  • Movement Disorders Section, Raul Carrea Institute for Neurological Research, FLENI, Montañeses 2325, C1428AQK Cdad. Aut. Buenos Aires, Argentina. · Pubmed 18329317
2015
  • Raul Carrea Institute for Neurological Research (FLENI), Neuroscience Department, Movement Disorders Section , Buenos Aires , Argentina. · Pubmed 25539892
2014
  • Raul Carrea Institute for Neurological Research, Movement Disorders Section , Montañeses 2325 (1425), Buenos Aires , Argentina +54 11 57773200 · +54 11 57773200 · · Pubmed 24673462
2012
  • Movement Disorders Section, Neuroscience Department, Institute for Neurological Research Raul Carrea, FLENI, Montañeses 232, 1428 Buenos Aires, Buenos Aires, Argentina. · Pubmed 22227345
2010
  • Movement Disorders Section, Raul Carrea Institute for Neurological Research, FLENI, Buenos Aires, Argentina. · Pubmed 19780806
2009
  • Movement Disorders Section, Raúl Carrea Institute for Neurological Research (FLENI), Buenos Aires, Argentina. · Pubmed 19916854
  • Movement Disorders Section, Neuroscience Department and Cognitive Department, Institute for Neurological Research Raul Carrea FLENI, Buenos Aires, Argentina. · Pubmed 19049504
2008
  • Neuroscience Department, Raul Carrea Institute for Neurological Research, Montañeses 2325, Buenos Aires, Argentina. · Pubmed 18568731
Miscellaneous cities in Argentina
2016
  • Movement Disorders, Raúl Carrea Institute for Neurological Research (FLENI), 2325 Montañeses St., Buenos Aires C1428AQK, Argentina. · Clinical Pharmacology and Epidemiology Laboratory, Pontifical Catholic University of Argentina, 1300 Alicia Moreau de Just Ave., Buenos Aires C1107AAZ, Argentina and Argentine National Scientific and Technological Research Council (CONICET), 1917 Rivadavia Ave., Buenos Aires C1033AAJ, Argentina. · Movement Disorders, Raúl Carrea Institute for Neurological Research (FLENI), 2325 Montañeses St., Buenos Aires C1428AQK, Argentina, Argentine National Scientific and Technological Research Council (CONICET), 1917 Rivadavia Ave., Buenos Aires C1033AAJ, Argentina · Pubmed 26512070
2015
  • Department of Clinical Pharmacology and Neurosciences, University Hospital and University of Toulouse 3, France. · INSERM CIC1436 and UMR825, Toulouse, France. · Laboratory of Epidemiology and Experimental Pharmacology, Institute for Biomedical Research (BIOMED), School of Medical Sciences, Pontifical Catholic University of Argentina (UCA). · National Scientific and Technological Research Council (CONICET), Buenos Aires, Argentina. · Clinical Pharmacology Unit, Instituto de Medicina Molecular, Lisbon, Portugal. · Laboratory of Clinical Pharmacology and Therapeutics, Faculty of Medicine, University of Lisbon, Portugal. · Pubmed 26293004
2014
  • Raul Carrea Institute for Neurological Research, Movement Disorders Section , Montañeses 2325 (1425), Buenos Aires , Argentina +54 11 57773200 · +54 11 57773200 · · Pubmed 24673462
Miscellaneous institutions in Toulouse
2012
  • Laboratoire de Pharmacologie Médicale et Clinique, Faculté de Médecine, Toulouse, France. · Pubmed 23123689
2011
  • Department of Clinical Pharmacology, Faculty of Medicine, Toulouse, France. · Pubmed 21453201
2009
  • Clinical Investigation Center and Neurosciences Institute, Department of Clinical Pharmacology, Faculty of Medicine, INSERM U 825, Toulouse, France. · Pubmed 19239399
4 Other Locations Show
Yearly article counts 02774383552
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.